Navigation Links
Therapy Trends: Multiple Sclerosis
Date:9/13/2012

NEW YORK, Sept. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Therapy Trends: Multiple Sclerosis

http://www.reportlinker.com/p0847521/Therapy-Trends-Multiple-Sclerosis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

 

 

 

An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse future trends.

 

 

Multiple Sclerosis: On the cusp of a treatment revolution

 

The year 2012 will see landmark changes in the treatment of MS. Gilenya, the first novel drug in five years, is to be joined by three new products; BG-12 from Biogen Idec, Sanofi's Aubagio and Genzyme's Lemtrada. These drugs will partially satisfy substantial unmet needs of convenient administration and more efficacious therapy to drive unprecedented market growth.

 

Driven by in-depth interviews with the world's leading multiple sclerosis KOLs, Therapy Trends: Multiple Sclerosis uncovers how the current treatment landscape will be impacted by significant future events, with particular focus on pipeline therapies and how these will modify the way MS is managed by neurologists in the future.

 

 

 

Drive your strategic decision-making with inside intelligence

Therapy Trends: Multiple Sclerosis disseminates critical opinion and analysis to provide premier research.

 

We cut to the heart of market-changing events and eliminate superfluous background information so you can focus on developments of greatest strategic impact and re
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Healthpoint Biotherapeutics Initiates Phase III Study of Unique Investigational Cell-Based Therapy for Venous Leg Ulcers
2. Kalidex Introduces Novel Fluoroquinolone, KPI-10, at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
3. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
4. NxStage Submits Formal Comments to CMS to Improve Patient Access to Life-changing More Frequent Home Hemodialysis Therapy
5. Institut Curie Acquires Four Advanced Radiotherapy Treatment Systems Including Three Varian TrueBeam Devices
6. ASRT Foundation and Elekta Award More Than $20,000 in Scholarships to Radiation Therapy Students
7. MAQUET Cardiovascular Announces Results Of The IABP-SHOCK II Trial Of Intra-aortic Balloon Counterpulsation Therapy In Cardiogenic Shock Patients
8. ATI Physical Therapy Selects Benefitfocus HR InTouch
9. Cancer Patients in Central Vietnam to Gain Access to Advanced Radiotherapy Treatments Using Technology from Varian Medical Systems
10. BioElectronics Topical Pain Therapy Now Available Throughout Europe
11. Express Scripts Launches Virtual Coaching To Help Patients Better Understand Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)...  Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a ... that Dr. Robert Grieve , the Company,s ... , executive vice president and chief financial officer, will ... being held May 30, 2013 in New York ... The Company,s presentation is scheduled to begin at 1:30 ...
(Date:5/24/2013)... 24, 2013  Sinovac Biotech Ltd. (NASDAQ: ... products in China , announced ... of Sinovac, obtained the Certificate of Good Manufacturing ... China State and Food Administration (CFDA) for its ... and its Changping filing and packaging facility. The ...
(Date:5/23/2013)... Inc. (Vanda) (NASDAQ: VNDA ) today announced that ... of the Year by the Tech Council of ... 25 th Annual Tech Awards Celebration held in ... the leaders and innovators in the technology and life science ... regions. "We are deeply honored to receive ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... -,Phytopharm plc (LSE: PYM) ("Phytopharm" or the ... reverses the,changes in the area of the ... be presented by Dr Jonathan Brotchie, an,internationally ... International Congress of Parkinson's Disease and Movement,Disorders' ...
... the Companies' Novel Heat Shock Protein 90 ... Biological,Activity , CAMBRIDGE, Mass. and GAITHERSBURG, Md., ... Inc. (Nasdaq:INFI) and,MedImmune, Inc. (Nasdaq:MEDI) today announced ... trial of the companies' heat shock,protein 90 ...
Cached Medicine Technology:Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 2Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 3Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 4Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 2Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 3Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 4Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 6Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 7
(Date:5/25/2013)... viruses and parasites that affect both dogs and humans, ... than can result in liver or kidney failure -- ... veterinarian. These germs could be found in ... Susan Nelson, a clinical associate professor at Kansas State ... can be fatal, even with treatment," she said in ...
(Date:5/25/2013)... St Louis, MO (PRWEB) May 25, 2013 ... goal for the Diet Doc team of weight management professionals. ... weight fast and effectively, Diet Doc’s hCG diets ... uncontrollable factors like abuse during childhood like bullying, more control ... not directly capable of dealing with the underlying factors of ...
(Date:5/25/2013)... 25, 2013 By working diligently for ... the integration of the 2012 Lamborghini Aventador into their ... latest entrant in the list of vehicles lined by ... is all set to thrill automobile lovers in the ... and spectacular looks, the 2012 Lamborghini Aventador comes with ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 According to ... most beautiful and powerful women that ever lived. Cleopatra’s ... by some of the most powerful men in her ... beauty remedies to keep her skin glowing and fresh, ... with bees- wax, maringa oil and cyprus grass. , ...
(Date:5/25/2013)... Houston, Texas (PRWEB) May 25, 2013 ... more stressful than finals week. Increasingly, they are ... them stay awake and study. For more on ... Associates, a drug treatment facility, warns that students ... through finals” are at risk for developing a ...
Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2
... , WEDNESDAY, Nov. 2 (HealthDay News) -- A new drug ... to improved lung function and fewer symptoms in people with ... -- is the first to halt the underlying processes that ... build up in the lungs and the pancreas and can ...
... WEDNESDAY, Nov. 2 (HealthDay News) -- The death toll in ... farm has reached 29, with another 139 people sickened in ... recently that the outbreak appeared to have been caused by ... Sept. 22 and 23 by federal and state authorities at ...
... not effectively prepare firefighters for the range of ... human factors/ergonomics researchers Michael R. Baumann, Carol L. ... 2011 Human Factors article, "Phased Training ... the authors assess the value of current scenario-based ...
... , WEDNESDAY, Nov. 2 (HealthDay News) -- Researchers using ... far determined that it was a child of a wealthy ... The mummy, owned by the Spurlock Museum at ... 1990, and more scans with updated CT technology this year. ...
... (HealthDay News) -- The legalization of medical marijuana in ... the availability and appeal of the drug among youth, ... the study, Rhode Island Hospital researchers examined adolescent marijuana ... 2009. Rhode Island legalized medical marijuana in 2006. ...
... from the University of Notre Dame,s Keck Center ... are joining forces to use a new medical ... patients.Researchers at the Keck Center investigate how the ... inflammatory diseases like sepsis, atherosclerosis and asthma. In ...
Cached Medicine News:Health News:New Drug Targets Underlying Cause of Cystic Fibrosis 2Health News:New Drug Targets Underlying Cause of Cystic Fibrosis 3Health News:New Drug Targets Underlying Cause of Cystic Fibrosis 4Health News:Death Toll From Listeria Outbreak Hits 29 2Health News:Death Toll From Listeria Outbreak Hits 29 3Health News:Current training programs may not prepare firefighters to combat stress 2Health News:Modern Technology Reveals Clues From Egyptian Mummy 2Health News:Univesity of Notre Dame researchers form new partnership to help trauma patients 2
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Span Diagnostics Limited...
Malaria (P. fal.) Ag Rapid Test...
OptiMAL is a malaria test, for diagnosis and therapy control of an infection by Plasmodium species (Malaria)....
Medicine Products: